| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/13/2005 | US20050008618 Composition for delivering an agent to a target cell and uses thereof |
| 01/13/2005 | US20050008602 Oligopeptides for promoting hair growth |
| 01/13/2005 | CA2542192A1 Look-through mutagenesis |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531103A1 Antibodies to the fuel oxygenate mtbe and use thereof in immunoassays |
| 01/13/2005 | CA2531023A1 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/13/2005 | CA2530797A1 Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
| 01/13/2005 | CA2530623A1 Assay for detecting atrial and brain natriuretic peptide prohormones |
| 01/13/2005 | CA2530591A1 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | CA2530393A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | CA2530272A1 Antibodies that cross-react with two or more kir2dl nk cell reporters and potentiate nk cell cytotoxicity |
| 01/13/2005 | CA2529578A1 Antibodies for use in increasing bone mineralization |
| 01/13/2005 | CA2528860A1 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | CA2528551A1 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof |
| 01/13/2005 | CA2527877A1 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | CA2527866A1 Modified antibody fragments |
| 01/13/2005 | CA2527373A1 Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease |
| 01/13/2005 | CA2527020A1 Modified antibody fab fragments |
| 01/13/2005 | CA2527003A1 Modified antibody fragments |
| 01/13/2005 | CA2520224A1 Immunogenicity-reduced anti-cr1 antibody and compositions and methods of treatment based thereon |
| 01/13/2005 | CA2518716A1 Inhibition of viral pathogenesis |
| 01/12/2005 | EP1496687A1 Digital camera |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496360A1 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor |
| 01/12/2005 | EP1496110A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 01/12/2005 | EP1496066A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 01/12/2005 | EP1495327A2 Method of determining whether a patient afflicted with cancer can be treated by a therapeutic agent that targets the 17-1a antigen |
| 01/12/2005 | EP1495325A1 Use of nucloeoside derivatives comprising a citrate group for producing antibodies having affinity for triphosphorylated nucleosides and uses thereof |
| 01/12/2005 | EP1495324A2 Use of monoclonal antibodies to distinguish protein conformational isoforms |
| 01/12/2005 | EP1495146A2 Antibody libraries |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495056A1 Antibody disulfide isomers, use thereof, and methods of analyzing same |
| 01/12/2005 | EP1495055A2 Production of functional antibodies in filamentous fungi |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1494714A2 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494712A2 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses |
| 01/12/2005 | EP1494711A1 Methods for treating chronic obstructive pulmonary disease (copd) |
| 01/12/2005 | EP1494710A2 Diabetes-related immunoglobulin derived proteins, compostions, methods and uses |
| 01/12/2005 | EP1494709A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1240361A4 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP1153039B1 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0891428B1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/12/2005 | EP0770088B1 Novel cytokine designated lerk-5 |
| 01/12/2005 | EP0751787B1 Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | EP0560890B1 A novel protein tyrosine kinase |
| 01/12/2005 | EP0318554B2 Targeted multifunctional proteins |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1563092A Recombining single chained three specific antibodies of anti CCA, anti CD 3, anti CD 28 through genetic engineering |
| 01/12/2005 | CN1563091A Method for extracting high active immunoglobulin in blood |
| 01/12/2005 | CN1563090A High performance quick purifying method for preparing piecewise antibody |
| 01/12/2005 | CN1563089A Monoclone antibody, polyclonal antibody of anti human's promoting growth factor (HAPO) of blood and vessel and its application |
| 01/12/2005 | CN1563088A Specific composite IgY for anti influenza and preparation |
| 01/12/2005 | CN1562963A Method for preparing 2 metho 4 chlorine artificial half antigen, artificial antigen, specific antibody and application |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/12/2005 | CN1183968C Improved vacines |
| 01/11/2005 | US6841659 Method for recovering proteins from the interstitial fluid of plant tissues |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841540 Immunomodulation by genetic modification of dendritic cells and B cells |
| 01/11/2005 | US6841531 For promoting the survival, growth, proliferation, or maintenance of mammalian neurons; accelerating wound healing while minimizing or inhibiting scar formation and keloid formation |
| 01/11/2005 | US6841383 Insertion of preferential nucleotide seqences into genome; ontain nucleotide sequences, incubate with cells, transform recover cell expressing preferential marker |
| 01/11/2005 | US6841353 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 01/11/2005 | US6841154 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and Staphylococcus aureus |
| 01/11/2005 | US6841153 Prevention of adhesions |
| 01/11/2005 | US6841152 Methods for protecting against autoimmune diabetes |
| 01/11/2005 | US6841147 Stem cell factor compositions |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2221712C A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/07/2005 | CA2470768A1 Crystal structure of osc |
| 01/06/2005 | WO2005001478A1 Methods for identifying agents, which regulate cytokines |
| 01/06/2005 | WO2005001421A2 Improved piezoimmunosensor |
| 01/06/2005 | WO2005001127A1 P53 as an indicator of cancer risk in different ethnic groups |
| 01/06/2005 | WO2005001096A1 Vaccines against sars |
| 01/06/2005 | WO2005001053A2 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist |
| 01/06/2005 | WO2005001048A2 Preparation and application of anti-tumor bifunctional fusion proteins |
| 01/06/2005 | WO2005001038A2 Recombinant anti-cd30 antibodies and uses thereof |
| 01/06/2005 | WO2005001033A2 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 01/06/2005 | WO2005001025A2 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/06/2005 | WO2005000902A1 The dimer of chimeric recombinant binding domain-functional group fusion formed via disulfide-bond-bridge and the processes for producing the same |
| 01/06/2005 | WO2005000901A2 Cd20-specific antibodies and methods of employing same |
| 01/06/2005 | WO2005000900A1 Treatment with anti-vegf antibodies |
| 01/06/2005 | WO2005000899A2 Modified binding molecules comprising connecting peptides |
| 01/06/2005 | WO2005000898A2 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions |
| 01/06/2005 | WO2005000897A2 Antibodies against interleukin-22 and uses therefor |
| 01/06/2005 | WO2005000896A2 Polypeptides that bind an anti-tissue factor antibody and uses thereof |
| 01/06/2005 | WO2005000894A2 Binding molecules for the treatment of myeloid cell malignancies |
| 01/06/2005 | WO2005000888A2 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |